Strep Throat Treatment Market Report 2024

The strep throat treatment market size has grown strongly in recent years. It will grow from $1.97 billion in 2023 to $2.08 billion in 2024 at a compound annual growth rate (CAGR) of 5.8%. The increase during the historical period can be credited to the growing occurrence of streptococcal infections, improved awareness and diagnosis, availability of antibiotics, healthcare infrastructure development, government health campaigns, a growing pediatric population, and economic expansion.

The strep throat treatment market size is expected to see strong growth in the next few years. It will grow to $2.62 billion in 2028 at a compound annual growth rate (CAGR) of 6%. The rise anticipated in the forecast period is attributed to the emergence of antibiotic resistance, adoption of telemedicine, global health initiatives, an aging population, enhanced healthcare access in developing regions, and investments in pharmaceutical research and development. Key trends expected in this period include the integration of telemedicine, innovation in rapid diagnostic tests, advancements in AI and machine learning, antibiotic research, progress in biotechnology, adoption of wearable health technologies, growth of e-pharmacies, and expansion of digital health solutions.

The strep throat treatment market is expected to grow due to the increasing incidence of bacterial infections. These infections are caused by harmful bacteria that invade the body, multiply, and release toxins. Factors contributing to the rise in bacterial infections include antibiotic overuse, global travel, urbanization, poor hygiene, and healthcare-associated infections. Strep throat treatment focuses on addressing bacterial infections through effective medication and care, which helps alleviate symptoms, shorten illness duration, and prevent complications. This approach supports healthcare providers in managing patient outcomes and controlling infection spread. For instance, a report by the UK's Office for Health Improvement and Disparities highlighted a significant increase in scarlet fever Group A Streptococcus bacteria notifications during the 2022-2023 season compared to previous years, underscoring the growing incidence of bacterial infections driving the strep throat treatment market.

Leading companies in the strep throat treatment market are innovating by developing new treatment options, including improved tablets and sprays. These products aim to enhance patient outcomes by relieving pain, soothing irritation, and providing temporary relief for throat discomfort associated with strep throat infections. For example, Mucinex introduced Mucinex InstaSoothe in November 2021, a product line tailored to alleviate sore throat pain and discomfort during cold and flu seasons. The lineup includes products such as Mucinex InstaSoothe Sore Throat + Soothing Comfort Lozenges, Mucinex InstaSoothe Sore Throat + Cough Relief Lozenges, and Mucinex InstaSoothe Sore Throat + Pain Relief Spray. These formulations incorporate specific active ingredients such as hexylresorcinol, dextromethorphan HBr, benzocaine, and menthol, designed to quickly numb, soothe, and alleviate sore throat pain for up to two hours.

In December 2021, Becton Dickinson and Company, a US-based medical technology firm, acquired Scanwell Health Inc. for an undisclosed sum. BD partnered with Scanwell to develop an app for the BD Veritor At-Home COVID-19 Test, which uniquely utilizes a smartphone camera and app to interpret results, reducing potential human error. Scanwell will now function as BD's digital platform for advancing at-home diagnostic tests across infectious diseases and chronic disease management. Scanwell Health Inc., headquartered in the US, specializes in digital healthcare, offering products for the treatment and diagnosis of infectious diseases, including smartphone-enabled at-home medical tests for conditions such as group A strep throat.

Major companies operating in the strep throat treatment market are Pfizer Inc., Johnson And Johnson, Merck And Co. Inc., AbbVie Inc., Bayer AG, Sanofi SA, Bristol-Myers Squibb Company, AstraZeneca plc, Abbott Laboratories, Novartis AG, F. Hoffmann-La Roche AG, Takeda Pharmaceutical Company Limited, GlaxoSmithKline plc (GSK), C.H. Boehringer Sohn AG And Co. KG, Eli Lilly and Company, Amgen Inc., Novo Nordisk A/S, Reckitt Benckiser Pharmaceuticals Inc., Teva Pharmaceutical Industries Ltd., Daiichi Sankyo Company Limited, Astellas Pharma Inc., Biogen Inc., Vertex Pharmaceuticals, Eisai Co. Ltd., Mylan N.V.

North America was the largest region in the strep throat treatment market in 2023. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the strep throat treatment market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

The countries covered in the strep throat treatment market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

Strep throat is caused by Group A Streptococcus bacteria, leading to infection primarily in the throat and tonsils. Symptoms include sore throat, difficulty swallowing, fever, swollen lymph nodes, and occasionally white patches on the tonsils. Treatment typically involves antibiotics such as penicillin or amoxicillin, along with pain relievers, rest, and fluids to manage symptoms, prevent complications, and support recovery.

Treatment for strep throat generally consists of antibiotics, pain relievers, and other supportive measures. Antibiotics are medications that kill or inhibit bacterial growth, serving as the primary treatment for strep throat by targeting the streptococcal bacteria responsible for the infection. Diagnosis methods include antibody tests, physical examinations, and throat cultures. Treatment options vary by type, including acute strep throat, pharyngitis, tonsillitis, and laryngitis, with administration routes such as oral, topical, or injectable. End users include hospitals, specialty clinics, diagnostic laboratories, and others.

The strep throat treatment market research report is one of a series of new reports that provides strep throat treatment market statistics, including strep throat treatment industry global market size, regional shares, competitors with an strep throat treatment market share, detailed strep throat treatment market segments, market trends and opportunities, and any further data you may need to thrive in the strep throat treatment industry. This strep throat treatment market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The strep throat treatment market consists of revenues earned by entities through services such as, antibiotic prescriptions, pain relief management, supportive care, and follow-up consultations. The market value includes the value of related goods sold by the service provider or included within the service offering. The strep throat treatment market also includes sales of throat lozenges and supportive care items such as throat sprays and herbal remedies. Values in this market are ‘factory gate’ values, that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.


This product will be delivered within 3-5 business days.